YangLiuMD

Oncology • Maplewood, MN

Physician

Join to view full profile

Dr. Liu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Liu's full profile

Already have an account?

Office
1580 Beam Ave
Maplewood, MN 55109
Phone+1 651-779-7978

Education & Training

University of Pennsylvania Health SystemResidency, Internal Medicine, 2013 - 2016
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Case Western Reserve University School of MedicineClass of 2013

Certifications & Licensure

MN State Medical License 2019 - 2025
WI State Medical License 2023 - 2023
PA State Medical License 2013 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin Start of enrollment: 2010 Mar 01
Terminated
Proficiency of Eye Drop Instillation in Postoperative Cataract Patients in Ghana Start of enrollment: 2012 Feb 01
Unknown status
Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial Start of enrollment: 2014 Jun 01
Recruiting
Not Applicable

Publications & Presentations

PubMed

15 citations
Validation of Breast Cancer Risk Models by Race/Ethnicity, Family History and Molecular Subtypes.
Anne Marie McCarthy, Yi Liu, Sarah Ehsan, Zoe Guan, Jane Liang
Cancers. 2021-12-23
18 citations
LYSMD3: A mammalian pattern recognition receptor for chitin.
Xin He, Brad A. Howard, Yang Liu, Aaron K. Neumann, Liwu Li
Cell Reports. 2021-07-20
24 citations
TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR).
Shuai Ye, Ying Liu, Ashley M. Fuller, Rohan Katti, Gabrielle E. Ciotti
Molecular Cancer Research. 2020-01-27

Abstracts/Posters

Impact of Novel Agents on Outcomes of Patients with Classical Hodgkin Lymphoma and Primary Treatment Failure
Yang Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019